Braskem S.A. (BAK) Stock Forecast
BAK analyst forecast
as of October 18, 2026- Analyst consensus
- Sell 2.17 / 5 from 6 analysts
- Price target
- $1.90 average of analyst targets
- Upside to target
- +14.5% from the latest close
- Next earnings
- November 10, 2026 EPS estimate $0.31
- 52-week range
- $1.42 – $5.02
BAK analyst ratings
6 analystsNumber of analysts at each rating.
BAK price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
BAK earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.31 | $0.31 | $0.31 | $0.00 | +6,932.9% | 1 |
| Current fiscal year (2026) | $0.53 | −$0.94 | $1.99 | −$4.59 | +111.5% | 2 |
| Next fiscal year (2027) | −$1.08 | −$1.38 | −$0.79 | $0.53 | −305.6% | 2 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
BAK revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $19.34B | $19.29B | $19.38B | +11.8% | 2 |
| Current fiscal year (2026) | $75.98B | $70.30B | $80.73B | +7.4% | 8 |
| Next fiscal year (2027) | $79.33B | $70.39B | $94.26B | +4.4% | 8 |
BAK EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
BAK revenue: reported and forecast
BAK EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | −$2.76 | −$2.76 | $0.31 | — | 1 up · 0 down |
| Current fiscal year (2026) | $2.55 | $2.55 | $0.00 | −$0.94 | $0.53 | −79.3% | 0 up · 0 down |
| Next fiscal year (2027) | −$0.54 | −$0.54 | −$1.83 | −$1.38 | −$1.08 | +102.0% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
BAK earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; BAK beat in 5 of 12.
What analysts expect from BAK
6 analysts cover Braskem; their consensus rating is sell (2.17 on a 1–5 scale, where 5 is a strong buy). The average price target is $1.90, 14.5% above the latest close of $1.66. Analysts expect earnings of $0.53 per share for 2026, +111.5% from a year earlier. For 2027 the average estimate is −$1.08 per share on revenue of $79.3 billion. Braskem beat the EPS estimate in 5 of the last 12 quarters.
Related: BAK income statement, BAK key metrics, BAK chart. See the BAK stock overview for the latest quote and news.
BAK forecast FAQ
What is Braskem's price target?
The average analyst price target for Braskem is $1.90, 14.5% above the latest close of $1.66.
Is Braskem a buy, hold or sell?
Of 6 analysts covering Braskem, 0 rate it a strong buy, 0 a buy, 3 a hold, 1 a sell and 2 a strong sell, a consensus of sell. Ratings are opinions, not a recommendation from Quotelinks.
What is Braskem's EPS forecast?
Analysts forecast $0.53 per share for 2026 (range −$0.94 to $1.99); for 2027 the estimate is −$1.08.
What is Braskem's revenue forecast?
The average revenue estimate for 2026 is $76.0 billion, growth of 7.4%; for 2027 it is $79.3 billion.
When does Braskem report earnings?
Braskem is expected to report results for the quarter ending September 30, 2026 on November 10, 2026; the EPS estimate is $0.31.
Does Braskem usually beat earnings estimates?
Braskem reported EPS at or above the analyst estimate in 5 of the last 12 quarters.